补充Bacillus subtilis养作为一种提高IgM标位和亲和力度的方法,以应对鱼类疫苗接种
Samuel Vicente-Gil1, Rocío Simón2, Silvia Nogales-Mérida2
1Biotechnology Department. National Institute of Agricultural and Food Research and Technology (INIA), Spanish National Research Council (CSIC), 28040, Madrid, Spain.
Fish & shellfish immunology
|April 15, 2025
概括
补充了益生菌Bacillus subtilis增强彩虹鱼的饮食.
科学领域:
- 水产养殖免疫学 水产养殖免疫学
- 鱼类的健康和营养
- 益生菌在水生动物中的应用.
背景情况:
- 益生菌,比如Bacillus subtilis,可以增强鱼类对病原体的免疫力.
- 益生菌饮食对鱼类疫苗反应的影响仍未得到充分研究.
- 彩虹鱼 (Oncorhynchus mykiss) 是一个重要的水产养殖物种.
研究的目的:
- 调查Bacillus subtilis补充饮食如何影响彩虹鱼对疫苗的适应性免疫反应.
- 评估益生菌饮食对抗体产生和亲和力的影响.
- 探索饮食策略在优化鱼类疫苗接种方案方面的潜力.
主要方法:
- 彩虹鱼在30天内接受了对照或补充Bacillus subtilis的饮食.
- 鱼类用不同的抗原进行免疫:TNP-LPS,Yersinia ruckeri bacterin和VHSV DNA疫苗.
- 测量了全身特异性IgM反应和抗体亲和力 (对于TNP-LPS).
主要成果:
- 补充细菌素的饮食对疫苗诱导的IgM抗体反应产生了积极的影响.
- 益生菌饮食也增强了对TNP-LPS的抗体亲和力.
- 这项研究表明,Bacillus subtilis对适应性免疫有有益影响.
结论:
- 补充Bacillus subtilis的食补充剂可以提高鱼类疫苗的疗效.
- 将益生菌纳入料是一种可行的策略,可以提高鱼类免疫结果.
- 整体疫苗接种方案应考虑饮食成分以及抗原和施用方法.
关键词:
2,4,6-三甲脂多聚糖化物 (TNP-LPS) 的使用抗体亲和力 抗体亲和力在IgM IgM中.益生菌 益生菌 益生菌彩虹鱼 彩虹鱼是一种疫苗接种 疫苗接种病毒性出血性败血病病毒 (VHSV)耶尔西尼亚·鲁克里 (Yersinia ruckeri) 是一种植物.更多相关视频
05:39Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
11.9K
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
1.9K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...